Uptake of a fluorescent-labeled fatty acid by spiroplasma floricola cells.
12-(1-pyrene)dodecanoic fatty acid (P12) uptake by Spiroplasma floricola BNR-1 cells was characterized with regard to its kinetics, specificity, metabolism and susceptibility to protein and lipid inhibitors. The uptake process depended on temperature and pH, and exhibited biphasic saturation kinetics with a very low (2.7 microM) and a high (37 microM) apparent Km value. Lauric, myristic, palmitic, stearic and oleic fatty acids did not compete with P12 for transport. The fluorescence of P12 was exclusively recovered in the neutral lipid fraction, suggesting that this fatty acid is not further utilized for phospholipid biosynthesis. Valinomycin, carbonylcyanide m-chlorophenyldrazone (CCCP), dicyclohexylcarbodiimide (DCCD), and pronase strongly reduced P12 uptake by cells, but not by membrane vesicles, affecting the high affinity (low Km) component of the uptake system. Uptake of P12 by cells, as well as by membrane vesicles, was very sensitive to glutaraldehyde, chlorpromazine, phospholipase A21 and ascorbate with FeCl3, which affected the low affinity (high Km) component of a transport system. Digitonin stimulated P12 uptake. We suggest that the incorporation of P12 into spiroplasma cell membrane is a two-step process: a high specificity energy-dependent and protease-sensitive binding to the outer surface of membrane, and a low specificity and energy-independent diffusion and partition into the membrane lipid environment.
Tarshis
M
M
Department of Membrane and Ultrastructure Research, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Salman
M
M
D001205:Ascorbic Acid / Q000494:pharmacology; D001692:Biological Transport; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone / Q000494:pharmacology; D002712:Chlorides; D002746:Chlorpromazine / Q000494:pharmacology; D004024:Dicyclohexylcarbodiimide / Q000494:pharmacology; D005290:Ferric Compounds / Q000494:pharmacology; D005456:Fluorescent Dyes / Q000378:metabolism*; D005976:Glutaral / Q000494:pharmacology; D007700:Kinetics; D007850:Lauric Acids / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008563:Membrane Lipids / Q000032:analysis; D008566:Membranes / Q000737:chemistry / Q000378:metabolism; D010741:Phospholipases A / Q000494:pharmacology; D011402:Pronase / Q000494:pharmacology; D013149:Spiroplasma / Q000378:metabolism*; D013347:Subcellular Fractions / Q000378:metabolism; D014634:Valinomycin / Q000494:pharmacology
D002712:Chlorides; D005290:Ferric Compounds; D005456:Fluorescent Dyes; D007850:Lauric Acids; D008563:Membrane Lipids; D014634:Valinomycin; D004024:Dicyclohexylcarbodiimide; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone; C040596:12-(1-pyrene)dodecanoic acid; D010741:Phospholipases A; D011402:Pronase; D001205:Ascorbic Acid; D005976:Glutaral; C024555:ferric chloride; D002746:Chlorpromazine